Recognizing and responding to anaphylaxis

i

Up-to-date Information: Up-to-Date Info : To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Recognizing and responding to anaphylaxis

Supporting Files Public Domain

File Language:

English

Details

Corporate Authors:

Centers for Disease Control and Prevention (U.S.).Office of Genomics and Precision Public Health.
Description:

Healthcare personnel should consider anaphylaxis when patients present with generalized signs or symptoms such as hives, serious or life-threatening symptoms (e.g., hypotension, respiratory distress, or significant swelling of the tongue or lips), or symptoms that involve more than one body system.

Detailed information can be found in the Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination

CS322867-A | 03/1/21

recognizing-responding-to-anaphylaxis-508.pdf
Subjects:

Anaphylaxis Coronavirus Infections/prevention & Control COVID-19 Vaccines/adverse Effects Pandemics Vaccination Viral Vaccines
Document Type:

Poster
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:0e22db4aa713ca321f1372a57a7910db08120c891480ec0607b83be2470b69e4
Download URL:

https://stacks.cdc.gov/view/cdc/106312/cdc_106312_DS1.pdf
File Type:

[PDF - 1.11 MB ]

managing-anaphylaxis.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fpfizer%2Fanaphylaxis-management.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.